These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 15168338)
21. Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer. O'Driscoll L; Linehan R; M Kennedy S; Cronin D; Purcell R; Glynn S; W McDermott E; D Hill A; J O'Higgins N; Parkinson M; Clynes M Cancer Lett; 2003 Nov; 201(2):225-36. PubMed ID: 14607338 [TBL] [Abstract][Full Text] [Related]
22. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis. Schiller AB; Clark WS; Cotsonis G; Lawson D; DeRose PB; Cohen C Cytometry; 2002 Aug; 50(4):203-9. PubMed ID: 12210599 [TBL] [Abstract][Full Text] [Related]
23. Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma. Mäkinen K; Hakala T; Lipponen P; Alhava E; Eskelinen M Anticancer Res; 1998; 18(1B):615-8. PubMed ID: 9568186 [TBL] [Abstract][Full Text] [Related]
25. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse. Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743 [TBL] [Abstract][Full Text] [Related]
26. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers. Zhang GJ; Kimijima I; Abe R; Watanabe T; Kanno M; Hara K; Tsuchiya A Anticancer Res; 1998; 18(3B):1989-98. PubMed ID: 9677455 [TBL] [Abstract][Full Text] [Related]
27. Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma. Magistrelli P; Coppola R; Tonini G; Vincenzi B; Santini D; Borzomati D; Vecchio F; Valeri S; Castri F; Antinori A; Nuzzo G; Caraglia M; Picciocchi A J Cell Biochem; 2006 Jan; 97(1):98-108. PubMed ID: 16173075 [TBL] [Abstract][Full Text] [Related]
28. Expression of Bcl-2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma. Yang Q; Sakurai T; Jing X; Utsunomiya H; Shan L; Nakamura Y; Nakamura M; Oura S; Suzuma T; Yoshimura G; Umemura T; Kokawa Y; Kakudo K Pathol Int; 1999 Sep; 49(9):775-80. PubMed ID: 10504548 [TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of p16INK4a/p53 in Tunisian patients with breast carcinoma. Karray-Chouayekh S; Baccouche S; Khabir A; Sellami-Boudawara T; Daoud J; Frikha M; Jlidi R; Gargouri A; Mokdad-Gargouri R Acta Histochem; 2011 Sep; 113(5):508-13. PubMed ID: 20598349 [TBL] [Abstract][Full Text] [Related]
30. BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma. Tang SC; Beck J; Murphy S; Chernenko G; Robb D; Watson P; Khalifa M Breast Cancer Res Treat; 2004 Apr; 84(3):203-13. PubMed ID: 15026618 [TBL] [Abstract][Full Text] [Related]
31. The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy. Skirnisdóttir I; Seidal T; Gerdin E; Sorbe B Int J Gynecol Cancer; 2002; 12(3):265-76. PubMed ID: 12060448 [TBL] [Abstract][Full Text] [Related]
32. [Correlations of HER-2, PCNA, Bcl-2, and Bax expression to prognosis of breast cancer]. Yang L; Zhu X; Ran L Ai Zheng; 2007 Jul; 26(7):756-61. PubMed ID: 17626754 [TBL] [Abstract][Full Text] [Related]
33. Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma. Lee WY; Jin YT; Tzeng CC Anticancer Res; 1996; 16(5A):3007-12. PubMed ID: 8917421 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma. Jia L; Esguerra RL; Tang X; Yin H; Sakamoto K; Okada N; Takagi M Pathol Int; 2004 Apr; 54(4):217-23. PubMed ID: 15028021 [TBL] [Abstract][Full Text] [Related]
35. The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer. Sjöström J; Blomqvist C; von Boguslawski K; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Wist E; Valvere V; Takayama S; Reed JC; Saksela E Clin Cancer Res; 2002 Mar; 8(3):811-6. PubMed ID: 11895913 [TBL] [Abstract][Full Text] [Related]
36. Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma. Pulkkinen JO; Klemi P; Martikainen P; Grénman R Anticancer Res; 1999; 19(1B):703-7. PubMed ID: 10216480 [TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53. Ong F; Moonen LM; Gallee MP; ten Bosch C; Zerp SF; Hart AA; Bartelink H; Verheij M Radiother Oncol; 2001 Nov; 61(2):169-75. PubMed ID: 11690683 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancers. Hanaoka T; Nakayama J; Haniuda M; Sato TA Int J Clin Oncol; 2002 Jun; 7(3):152-8. PubMed ID: 12109516 [TBL] [Abstract][Full Text] [Related]
39. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232 [TBL] [Abstract][Full Text] [Related]
40. Drug-induced apoptosis and p53, BCL-2 and BAX expression in breast cancer tissues in vivo and in fibroblast cells in vitro. Suzuki K; Kazui T; Yoshida M; Uno T; Kobayashi T; Kimura T; Yoshida T; Sugimura H Jpn J Clin Oncol; 1999 Jul; 29(7):323-31. PubMed ID: 10470656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]